The US Food and Drug Administration (FDA) has granted Fast Track designation for Eli Lilly and Company’s tirzepatide to treat adults with obesity or overweight with weight-associated comorbidities. On holding talks with the regulatory agency, the company intends to...
Surrozen and Boehringer Ingelheim have entered a partnership and licence agreement for researching and developing SZN-413 to treat retinal diseases. The collaboration will merge the SWAP technology of Surrozen for Wnt signalling modulation with the research and...
Nested Therapeutics uses computational techniques to map mutations and protein structures, identifying previously unseen places where a cancer drug can bind. The Versant Ventures-founded startup is now out of stealth with two programs on the path to the clinic.
Northwell recently invested $3 million in Hume AI, an expressive communication research lab and AI startup. The health system is partnering with Hume to develop machine learning models designed to better understand patients’ vocal and nonverbal communications.
TALON was recently crowned winner of the Pitch Perfect contest at MedCity’s Invest Digital Health conference in Dallas. The company offers a suite of solutions to help stay compliant with the Transparency in Coverage Rule.
Enrollees in high-deductible health plans are 6.6% less likely to receive substance use disorder treatment than those without a high-deductible health plan. Having a high-deductible health plan led to 21% less health plan spending, but an increase of 14% in...
